Lysosomal Acid Lipase Deficiency in Risk Groups — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lysosomal Acid Lipase Deficiency in Risk Groups — Stella

Recruiting

Back to Lysosomal Acid Lipase Deficiency trials

Trial locations(2 sites)

Russia

Research site, Nizhny Novgorod

Research Site, Saint Petersburg

Key details

Sponsor

AstraZeneca

Enrollment target

~1,200 participants

Started

February 2026

Primary completion

June 2028

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov